Feds now say they shouldn’t have spent tax dollars to prosecute Washington medical marijuana growers

 

The “Kettle Falls Five“, who were convicted on charges after a 2011 raid of their farm, may have their sentences dropped, thanks to the Rohrabacher-Farr spending amendment

Rhonda Lee Firestack-Harvey, left, Jason Zucker, Rolland Gregg and Michelle Gregg stand with Larry Harvey outside the Thomas S. Foley United States Courthouse on Thurday, Feb. 12, 2015, in Spokane, Wash. A federal judge will decide whether the criminal case against the Kettle Falls Five will take place later this month. DAN PELLE danp@spokesman.com

By The Associated Press

SPOKANE, Wash. — The convictions of some Washington residents for growing marijuana near the town of Kettle Falls may soon be erased.

That’s after federal prosecutors acknowledged that they shouldn’t have spent money on the trial of the so-called Kettle Falls Five in 2015, or on the appeals since.

That acknowledgement came more than two years after prosecutors convinced a federal judge that they had the authority to try the medical marijuana growers, The Spokesman-Review reported Thursday.

But Assistant U.S. Attorney Earl Hicks said Wednesday that federal law has changed in regards to spending and asked that the case be returned to the trial judge for further proceedings.

Related: The feds seized guns, gold and 320 pot plants. So why did a judge rule they can’t pursue marijuana charges?

Hicks filed documents with the 9th U.S. Circuit Court of Appeals this week that said recent rulings on other medical marijuana cases have convinced him that the Spokane office didn’t have authority to spend money on the 2015 trial or on the pending appeals.

A defense attorney said he plans to file a motion soon to dismiss the convictions.

“This really feels like vindication,” said defense attorney Phil Telfeyan of Washington, D.C., who represents Rolland Gregg.
“Unbelievable,” said Frank Cikutovich, a Spokane attorney who represents defendant Jason Zucker.

Zucker took a plea deal on the eve of the trial. But Zucker’s plea agreement said that anything that happens in the appeal of the other defendants would apply to him, Cikutovich said.

Congress in late 2014 cut off funds for federal prosecution of people who were growing and using medical marijuana in states where that was legal. That restriction has been renewed in every subsequent budget.

At that time, the five defendants — Larry Harvey; his wife Rhonda Firestack-Harvey; their son Rolland Gregg and his wife Michelle; and family friend Zucker — were awaiting trial on charges stemming from a 2011 raid on the Harvey’s farm near Kettle Falls. Federal and local agents seized marijuana plants and firearms on the property.

In a case that drew nationwide attention, the federal government charged them with growing and trafficking in marijuana and added firearms charges that would have extended their sentences.

The defendants contended that the marijuana plants were allowed by state law and that the guns were used for hunting.

Prosecutors in Spokane continued to press the case even after the cutoff of federal funds for prosecution in 2014.

Larry Harvey was dismissed from the case just before trial because he had terminal pancreatic cancer, and has since died. Zucker made his plea agreement just before trial and was sentenced to 16 months.

U.S. District Court Judge Thomas Rice

U.S. District Court Judge Thomas Rice would not allow any reference that Washington had legalized medical marijuana during the trial for the remaining three defendants. The jury convicted Firestack-Harvey and the Greggs of growing between 50 and 100 marijuana plants, and dismissed the other charges.

 

Rolland Gregg was sentenced to 33 months in prison and the two women to 13 months each. They remained free on bond pending appeal.

Information from: The Spokesman-Review

 

 

 

http://www.thecannabist.co/2017/10/19/kettle-falls-five-washington-marijuana/90464/

Annunci

Ddl cannabis, intervista a Giachetti: ecco perché ho votato contro la mia legge per la legalizzazione

Roberto Giachetti, parlamentare del Partito Democratico, è stato il primo firmatario della proposta di legge per la legalizzazione della cannabis.

in Cannabis / High times  20 ottobre 2017

Una foto diffusa dallo stesso Roberto Giachetti su Facebook

Una proposta che mirava a rendere legale la coltivazione a uso personale e il commercio di cannabis. Ieri in aula ha votato contro la sua stesse idee, aderendo alla linea del suo partito. Pur ribadendo nella dichiarazione di voto di essere un convinto antiproibizionista ha di fatto contribuito a porre la pietra definitiva su ogni residua possibilità di approvare una qualche riforma della legislazione sulle droghe in questa legislatura.

Una posizione che gli è valsa la critica unanime dei movimenti antiproibizionisti e dei malati che si battono per il libero accesso alle cure a base di cannabinoidi, che hanno visto per l’ennesima volte le proprie aspettative tradite. Lo abbiamo raggiunto al telefono per chiedergli spiegazioni sui motivi che lo hanno portato a questa scelta.

 

Per quale ragione ha votato contro la legge per la legalizzazione, della quale era stato addirittura il primo firmatario?

 

Fino all’ultimo momento prima del voto ho fatto la mia battaglia dentro al Partito Democratico per convincere i miei compagni di partito a votare in favore della legalizzazione o per concedere almeno libertà di scelta ai deputati. Purtroppo ho perso la battaglia e la maggioranza del partito ha deciso di votare contro la mia legge. Ho ribadito che credo si sia trattato di un grave errore politico, ma per me il Pd è una comunità, credo nella democrazia interna e nella disciplina di partito, quindi mi sono adeguato. Tra l’altro è stata approvata la proposta Miotto, che comunque segna un passo avanti e che in alcune sue parti faceva parte della proposta di legge della quale ero primo firmatario. Quindi un piccolo passo avanti si è fatto.

 

La legge Miotto è stata criticata dagli stessi malati, che la giudicano inutile per migliorare le loro condizioni di accesso alla cannabis terapeutica.

Era l’unico testo di legge che si poteva approvare, dati i numeri. Anche l’emendamento che proponeva per i soli malati la possibilità dell’autoproduzione della cannabis non è passato nonostante il voto a scrutinio segreto che ha permesso sicuramente a diversi deputati di votare secondo coscienza senza seguire le direttive del partito.

 

Lei come ha votato negli emendamenti a scrutinio segreto?

Ho già detto che credo nella disciplina di partito e nel rispetto di ciò che viene deciso dalla maggioranza del mio gruppo politico. Per me è un principio guida, quindi non è che cambio il voto solo perché è anonimo. Ho votato contro l’autoproduzione.

 

Possibile che la disciplina di partito valga più dei diritti di migliaia di malati?

Capisco la loro delusione, ma la risposta è sì. Faccio parte di una comunità politica e ne rispetto le scelte. Se cade questo principio, per come la vedo, cade l’essenza stessa del fare politica in un partito.

 

I membri dell’interguppo “cannabis legale” aderenti al Pd sono abbastanza numerosi per minare la stabilità del governo, almeno al Senato. Non avreste potuto fare maggiori pressioni all’interno del partito per ottenere qualcosa di più?

Se allude alla possibilità di minacciare una crisi di governo, ammesso che ce ne fossero i numeri, le dico che noi non vogliamo tornare alla prima repubblica e alla politica dei ricatti. Abbiamo fatto una battaglia, l’abbiamo persa, ci adeguiamo e riprenderemo la lotta appena sarà possibile.

 

Tuttavia non è certo la prima volta che lei si trova in contraddizione col partito di cui fa parte, specie per quanto riguarda i diritti civili, non le viene mai il dubbio di aver sbagliato gruppo politico?

No, credo ancora che il modo più utile per difendere le mie idee, tra le quali la legalizzazione della cannabis, sia continuare a fare battaglia dentro al Pd. Tornando al voto di ieri mi faccia aggiungere un dato: mi pare che si facciano le pulci solo a noi antiproibizionisti del Pd, ma tra gli aderenti all’integruppo per la legalizzazione di movimento 5 stelle, sinistra italiana e Mdp c’erano 34 assenti. Se fossero stati tutti presenti gli emendamenti per l’autocoltivazione sarebbero passati. Potrebbero fare autocritica e invece attaccano me.

A questo punto della legislatura ogni speranza di un miglioramento della legislazione sulla cannabis è definitivamente caduta?

Direi di sì, non c’è più tempo. Se sarò ancora in parlamento riprenderò la battaglia dal primo giorno della prossima legislatura. Ma sempre all’interno della mia comunità politica, che è il partito democratico.

 

 

 

http://www.dolcevitaonline.it/ddl-cannabis-intervista-a-giachetti-ecco-perche-ho-votato-contro-la-mia-legge-per-la-legalizzazione/

These Are the First Two Licensed Jamaican Cannabis Companies

While Jamaican cannabis has a rich history, the country of Jamaica hasn’t been at the forefront of the legal industry; however, that may soon change as the country has issued its first two Jamaican cannabis licenses.

On Oct. 18, 2017, the Cannabis Licensing Authority announced that it had awarded a Tier 1 cultivation license to Epican, permitting the company to grow up to 1 acre of cannabis, and a Tier 1 processor license to Everything Oily, enabling the company to process medical cannabis in a space up to 200 square meters in size.

“Although it has taken some time to get to this historic occasion, we have remained committed to getting it right, to ensure that Jamaica’s stake in the global medicinal cannabis industry is never compromised and remains sustainable,” said Hyacinth Lightbourne, Chairman of the CLA, in a press release. “During the process, we have endevoured to remain in dialogue with our applicants every step of the way, and are confident they have satisfied the rigors of the regulations; and now we are pleased to announce that Epican and Everything Oily will be issued licences today.”

During the licensing ceremony held on Oct. 18 at the Ministry of Industry Commerce Agriculture and Fisheries, Epican and Everything Oily signed a tripartite agreement to do business together.

According to Lightbourne, “The CLA now has another three applicants who have been granted licences and are completing their requirements to be issued, 57 at the conditional approval stage, and another 209 applications being processed.”

Agriculture Minister Karl Samuda is pleased with the CLA’s diligence in processing applications and the issuance of the first two Jamaican cannabis licenses, but he wants to make sure Jamaica doesn’t “miss the boat.”

“I just ask that the board be very careful, but at the same time be very swift in the discharge of your responsibilities,” Samuda said, as reported by The Gleaner.

 

 

http://mjinews.com/jamaican-cannabis-companies-licenses/

M5S: i malati sono stati traditi ancora una volta, serve un referendum consultivo sulla cannabis

Dopo il voto di ieri, che ha visto naufragare per una manciata di voti due emendamenti che avrebbero consentito l’autoproduzione di cannabis per i malati, il Movimento 5 Stelle, ha emesso un duro comunicato, nel quale punta il dito contro il Partito Democratico, accusandolo di aver tradito i malati, e preannuncia il tentativo – per la prossima legislatura – di cercare di indire un referendum popolare consultivo sulla legalizzazione. Ecco il testo.

promotore dell’emendamento per l’autoproduzione bocciato ieri dalla Camera

in Cannabis / High times  20 ottobre 2017

“Il Movimento 5 Stelle ha votato favorevole per senso di responsabilità nei confronti dei tanti malati che chiedono un intervento in materia, sperando che il Senato possa approvare questa legge. Siamo contenti che, grazie anche alla nostra insistenza, per la prima volta si sia discusso alla Camera dei Deputati di legalizzazione della cannabis. È solo il primo passo, nella prossima legislatura l’argomento dovrà essere affrontato anche attraverso un referendum popolare consultivo, così che i partiti non potranno più nascondersi e dovranno prendersi le loro responsabilità.

Negare la legalizzazione è stato l’ultimo atto ipocrita del PD, che permette alla criminalità di prosperare. Una scelta ideologica, falsa e dannosa che non vuole vedere quanto sta accadendo a livello internazionale: la legalizzazione sta portando un sostanziale abbassamento dei reati, maggiori entrate fiscali, una diminuzione del consumo soprattutto tra i giovani . Non è bastato al PD quanto affermato dalla Direzione Nazionale Antimafia e Antiterrorismo che i tempi erano maturi per legalizzare, perché la criminalizzazione non ha prodotto nessun effetto, se non quello di aumentare il consumo, le entrate alla mafia ed il contatto dei giovani con il crimine, droghe pesanti e sostanze tossiche.

Anche in Italia potremmo controllare il fenomeno regolamentando un mercato che di fatto è già libero. In questo modo si potrebbero impegnare le forze dell’ordine ed i magistrati sul perseguimento di reati gravi e al contempo destinare una parte di quelle risorse economiche alla giustizia, alla prevenzione dell’utilizzo di droghe, alla sanità. Perché i partiti contrari non hanno fatto proposte contro tabacco e alcool visto che provocano migliaia di morti ogni anno in Italia? Mentre non c’è un morto accertato per uso di cannabis, una vera e propria ipocrisia.

Nulla da fare il PD e la sua strampalata maggioranza hanno eliminato la parte su coltivazione per uso personale e monopolio di Stato sulle vendite, tutto questo lasciando solo la parte terapeutica che il Ministro Lorenzin con un Decreto Ministeriale poteva risolvere senza perdere ulteriore tempo; tempo che manca ai tanti malati che oggi in Italia non riescono ad accedere alle cure a base di cannabis. La cosa più triste è vedere che a distruggere questa legge non sono stati solo i rappresentanti di Lega Nord, FI, e FdI che ideologicamente rigettano anche i dati più evidenti, ma gli stessi deputati del PD che hanno sottoscritto la proposta di legge dell’intergruppo per la legalizzazione: Giachetti e Giuditta Pini in testa, che hanno tradito il lavoro che avevano sostenuto in questi anni”.

 

 

 

 

http://www.dolcevitaonline.it/m5s-i-malati-sono-stati-traditi-ancora-una-volta-serve-un-referendum-consultivo-sulla-cannabis/

PETITION: DEA NEEDS TO UPDATE CONTRADICTING MARIJUANA INFORMATION IN DEA PUBLICATIONS

NEWEST DEA PUBLICATION STATES MARIJUANA IS NOT A “GATEWAY DRUG”, DOESN’T CAUSE COGNITIVE DECLINE, PSYCHOSIS OR LUNG CANCER

Petition: DEA Needs To Update Contradicting Marijuana Information In DEA Publications – Since the day Obama became president, there have been rumors that on his last day of office he would somehow do a mic drop and make marijuana legal. This is not legally possible but there is something he could do before he leaves office to finally put an end to “reefer madness”: update the Drug Enforcement Administration’s (DEA) website and publications to reflect its own recent scientific findings on medical cannabis. Science that dispels four of the biggest myths about medical marijuana. Requiring scientific accuracy would allow Congress and the next Administration to have accurate information when discussing national medical cannabis policies that affects millions of Americans.
In August 2016, the DEA issued the “Denial of Petition to Initiate Proceedings to Reschedule Marijuana,” in response to Washington and Rhode Island’s attempts to reschedule cannabis While the DEA did not reschedule cannabis, the report did clarify four important misconception about medical cannabis: that cannabis was a “gateway drug”, or that it caused cognitive decline, psychosis and lung cancer.
These arguments, especially the “gateway” theory, have been a centerpiece in the drug war for decades. All four are now disproven by the DEA’s own research. It is a pretty small ask for Obama require it to use its own data.

 

CONTRADICTIONS

The report also contradicted two earlier reports from the DEA, “The Dangers and Consequences of Marijuana Abuse” and “Drugs of Abuse.” Following the release of the DEA’s August report, Americans for Safe Access (ASA) released a paper which asked the Department of Justice (DOJ) and DEA to update contradicting information in the DEA publications. By December, neither agency had responded.

The lack of action led ASA to file a petition with the DOJ utilizing rights granted to our members and patients under the Information Quality Act (IQA). Passed in 1994, the law simply mandates that the data the government uses must be truthful. The IQA requires administrative agencies to devise guidelines that ensure the “quality, objectivity, utility, and integrity of information” they distribute and to “[e]stablish administrative mechanisms allowing affected persons to seek and obtain correction of information maintained and disseminated by the agency that does not comply with the guidelines.”
The petition identifies 25 violations of the IQA on the DEA’s website and publications and includes suggested changes based on the DEA’s own words from their August report.
Congress and the White House rely on the DEA to provide current and accurate information when they are making decisions about marijuana policy. Congress has voted against medical cannabis policy due to this inaccurate and outdated information, in fact Reps. Fleming , Wolf, Harris, and Sens. Graham, Feinstein, Grassley, and Sessions have all cited this information in hearing testimony or as reasons for their colleagues to vote against medical cannabis legislation.
Most importantly, Attorney General nominee Jeff Sessions has his biases but listens to the DEA. At a hearing in 2014 he said:

“I thank you for you and some of your officials in DEA for speaking out and telling the truth about the dangers of marijuana. This is not a non-dangerous drug. And I’ve got to tell you in terms of messaging, the president’s statement — to me, I spent 12 years working with grassroots citizens’ groups to change the approach to drugs and the climate of drugs and to make it hostile climate for drugs and explain the dangers of drug use.”

CONGRESS

If Congress is going to finally end the conflict between state and federal law, they will need to have accurate information. Granting the IQA petition will mean that we can break through the myth-induced gridlock and advance the dialog on medical cannabis so that a federal policy can be established that respects the rights and needs of patients.
Correcting the DEA’s website and publications is in line with Obama’s hopes when he first came into office. In the first months of his Presidency, Obama issued a memorandum to the heads of executive departments and agencies stating that, “The public must be able to trust the science and scientific process informing public policy decisions,” and calling for “transparency in the preparation, identification, and use of scientific and technological information in policymaking.”
Success in correcting this information will mean politicians can no longer use the misinformation about the gateway drug hypothesis, irreversible cognitive decline in adults, and cannabis causing psychosis or lung cancer to deny patients access to medical cannabis.

Today over 300 million Americans live in states where medical cannabis is in some form is legal. Over 2 million patients across 44 states are legally using medical cannabis according to under their state laws. However, medical cannabis is still illegal federally and the only thing protecting medical cannabis programs and the patients they serve from federal intervention is a memo from the DOJ and a line in a Congressional budget amendment. Both of which are in jeopardy under the new administration and in the 115th Congress.
Please join the over 80,000 people in urging Obama to require the DEA to consistently tell the truth by signing and sharing this petition.

From The Huffington Post

https://medicalmarijuana411.com/petition-dea-needs-update-contradicting-marijuana-information-dea-publications/?utm_source=newsletter101917&utm_medium=email&utm_campaign=dailydose&utm_content=readmore

SENATOR DIANNE FEINSTEIN CANNABIS VIEWS DIFFER FROM CHALLENGER KEVIN DE LEÓN

Senator Dianne Feinstein

Senator Dianne Feinstein has experienced a successful career in California politics. She has been actively involved in public life since the 1960’s. She took over as the mayor of San Francisco in 1978 and has served as a United States Senator for the past 25 years. Last week, Senator Feinstein announced that she will be campaigning for her sixth consecutive term.

 

MEET CHALLENGER KEVIN DE LEÓN

Kevin de León

California Senate President pro tempore Kevin de León announced he will run against Feinstein for the California Senate seat. Unlike the moderate Feinstein, de León is a hyper-progressive politician who has fought for “progressive California values in important policy efforts like immigration, women’s rights, quality education, civil rights, job creation and fighting climate change.”

 

While he hasn’t been an active vocal supporter of reform, de León has received praise from cannabis advocates for his progressive views on cannabis. He has voted in favor of marijuana legalization in the past, including the Prop 64 vote in 2016 which legalized adult recreational cannabis use in the state of California.

 

SENATOR DIANNE FEINSTEIN CANNABIS STANCE

Feinstein has been a key figure for the Democratic party over the past 25 years. Yet she has been one of the most outspoken critics of cannabis reform during her time in office. Diane Finestein cannabis reformIn fact Senator Feinstein voted against Proposition 215 in 1996 – which legalized medical marijuana use in California. She also did not support Proposition 64 in 2016. Feinstein said she was concerned about “millions of children and teenage viewers” being brainwashed into using cannabis- a statement that a Prop 64 spokesman said was “reminiscent of the ‘reefer madness’-style disinformation campaigns that subverted honest dialogue around this issue for decades.”

Feinstein has also voted against the Rohrabacher-Farr amendment that aims to protect medical marijuana states from Justice Department infringement. Based on her voting record, Senator Feinstein is clearly against the idea of legalizing marijuana in California.

We don’t know if de León will challenge Senator Feinstein on her anti-cannabis views. Some think this would be a valuable political tool for de León, who is running against Feinstein from the left to challenge her antiquated views on cannabis and its affect on society. A de León victory would be a boost for pro-marijuana legislators in Congress.

 

WHY PRO-CANNABIS CONGRESS MEMBERS WANT A DE LEÓN VICTORY

Currently, the Congress has very few members who openly support cannabis legalization. The bipartisan Congressional Cannabis Caucus, formed in February of this year, has only four members and has yet to push any meaningful legislation into law.

One of its members, Republican Representative Dana Rohrabacher, is half of the namesake for the Rohrabacher-Farr amendment that he believes won’t be renewed in the 2018 budget bill. If this bill is eliminated, the Jeff Sessions led Justice Department will no longer be blocked from using federal funds to prosecute states where medical marijuana is currently legal. If this happens California dispensaries and growers will see regular DEA raids.

California voters will likely identify more with de León’s progressive views on cannabis legalization. He will still likely face an uphill battle against Senator Feinstein, who in 2012 received more votes than any Senatorial candidate in U.S. history.

 

 

 

https://medicalmarijuana411.com/senator-dianne-feinstein-cannabis-views/?utm_source=newsletter101917&utm_medium=email&utm_campaign=dailydose&utm_content=readmore

Greek official calls for marijuana legalization

Yiannis Tsironis

On Greek TV, a Greek official calls for marijuana legalization for recreational purposes. The official in question is Yiannis Tsironis. He’s the Deputy Minister for Agriculture, originating from Greece’s Green Party. Yeah, we figured as much.

The Green in Greece

Like many other countries, our own included, Greek federal policy outlaws cannabis.Despite the country’s history of producing hashish, authorities officially criminalized the plant in 1890. Although the cultivation and possession of hashish were illegal, Greek citizens continued to use it. Particularly after the first World War. Greek soldiers, as well as refugees from other countries, used cannabis. The prohibition was not particularly forceful or effective at that point.

Although cannabis (and other drugs) is still illegal in Greece, lawmakers have eased the policies regarding it.

The penalty for getting caught still may include jail time. But the courts recognize the difference between drug users and drug traffickers. Greek courts also make a distinction between cannabis and what they deem “dangerous drugs” like heroin.

This year, the Greek Prime Minister, Alexis Tsipras, legalized marijuana for medicinal purposes, thus becoming the latest European country to implement a nation-wide medical marijuana program. At the moment, weed is still illegal for recreational purposes.

But will it always be?

Recently, the Deputy Minister for Agriculture, Yiannis Tsironis, stated his opinion that Greek lawmakers should fully legalize cannabis in the country. He even said that Greek citizens should be able to legally grow cannabis plant on their property.

Tsironis cited the drug abuse problem in Greece as a reason for his position to legalize marijuana. In the interest of harm reduction, Tsironis said that he wants addicts to be able to purchase drugs legally. And so, the Greek official called for marijuana legalization in his home country.

Final Hit: Greek Official Calls For Marijuana Legalization

Would something like this actually work?

While we can all agree that marijuana legalization, or at least decriminalization, would be absolutely positive, can we say the same of other drugs? It’s actually not the most outlandish idea.

In 2001, Portugal decriminalized all drugs to combat the epidemic of addiction in their country. Instead of automatic jail sentences for those the police caught with drugs, courts handed out civil penalties and health interventions.

The result?

Deaths from drug overdoses plummeted. Addicts took advantage of the health interventions. Turns out that most people addicted to drugs don’t want to be.

Because we know that cannabis is non-addictive and not even in the same ballpark as harder drugs, decriminalization and legalization seems like an obvious route to go. Especially in the interest of public health and overcrowding in prisons, among other things. Tsironis has started the conversation and debate on cannabis legalization in Greece. It’s only the first step to real change, but still, it’s a step. Hopefully, Greece will legalize the plant, and hopefully, it will help alleviate some of the struggles of addiction in their country. At the very least decriminalization could be a good start to the social progress they seem to want to make.

 

 

http://420intel.com/articles/2017/10/17/greek-official-calls-marijuana-legalization?utm_source=420+Intel+-+Marijuana+Industry+News&utm_campaign=a11f5770b6-420+Intel&utm_medium=email&utm_term=0_3210cbef52-a11f5770b6-270890321

Israeli medical marijuana goes global

After holding its third innovation conference in Tel Aviv in March, iCAN: Israel-Cannabis — an Israeli marijuana group — is hosting the inaugural CannaTech UK convention on October 26 at London’s Old Truman Brewery.

 by Marijuana News on Wed, 10/18/2017

The Israeli organization’s stated mission is “to identify, invest, accelerate and showcase cannabis innovation for the global cannabis economy.” At the UK gathering, industry professionals and enthusiasts will network and enjoy a series of TED-style lectures; the event will be Britain’s first-ever international conference on innovation in this field.

Although CannaTech is an Israeli brand, the UK event has been curated specifically for a British and European audience, and will provide a broad overview of the latest cannabis research, medical applications and scientific innovations in Europe and globally.

Saul Kaye, the CEO of iCAN

Israel can offer European countries expertise on “how to grow [medical cannabis], how to build a sustainable industry that crosses into pharmaceuticals and regular distribution, [and] how to get medical access to patients before the science is in,” Saul Kaye, the CEO of iCAN, told JNS.org.

The event will address cannabis regulation challenges that are unique to Europe, and help facilitate a special investor symposium, showcasing cannabis investment opportunities and start-ups.

According to Kaye, the UK was selected to host the first CannaTech conference outside of Israel in part due to Britain’s history of encouraging debate through its parliamentary style of government. The UK was also picked based on the belief that dialogue will lead to normalization of medical cannabis in the country.

“We chose the UK because they’re behind in medical cannabis policy and they have a lot to learn from Israel,” said Kaye. “We have patients [in the UK] that we know are in desperate need, and London is a financial hub of the world, so we felt it prudent to bring CannaTech there, and so far we’ve been proven right.”

He added that, “there’s a lot Israel can learn [about medical cannabis] from foreign countries as well.”

The UK event will feature presentations from Israeli experts such asDr. William Levine, executive director of CannRx,andLihi Bar Lev founder of the research department at Tikun Olam, Israel’s first and largest medical cannabis supplier.

“As a pharmacist, my passion is in formulation, and we are working together with our partners to bring game-changing pharmaceutical grade cannabis products to market with innovative delivery methods,” Kaye said.

In countries such as the US, the ability to conduct research on marijuana is nearly impossible because of the status of cannabis as a Schedule I substance.

Hebrew University professor Raphael Mechoulam

In recent years, Israel has become a hub for the study and distribution of medical cannabis. Hebrew University professor Raphael Mechoulam initially discovered THC, the primary psychoactive compound in the cannabis plant, in the 1970s. Since then, Israeli hospitals have demonstrated a willingness to perform clinical trials on the effectiveness of cannabis in relieving the symptoms of tens of thousands of patients, all suffering from chronic or terminal conditions.

“Israel’s medical cannabis program is the oldest and most advanced in the world,” said Kaye. “Our regulatory environment allows for clinical trials to test efficacy on a variety of illnesses, and our government has even provided grants for several cannabis companies.”

In addition to becoming a leader in medical cannabis research and development due to its unique regulatory environment, Israel stands to generate large profits from the industry.

In March, the Knesset passed a new law essentially decriminalizing recreational marijuana use nationwide, and in August, a joint committee of the Israeli Health and Finance ministries approved a new measure allowing for international exportation of the plant. According to some reports, Israel could earn up to $4 billion annually in revenue from medical cannabis exports.

Prior to the measure’s approval, several European countries expressed strong interest in importing Israeli medical cannabis and applied for permission to do so, including Germany, Denmark, the Czech Republic and Cyprus; this makes the upcoming CannaTech UK conference especially timely, since it caters specifically to the medical cannabis needs of European nations.

 

 

 

http://420intel.com/articles/2017/10/18/israeli-medical-marijuana-goes-global?utm_source=420+Intel+-+Marijuana+Industry+News&utm_campaign=6a1bc8fe41-420+Intel&utm_medium=email&utm_term=0_3210cbef52-6a1bc8fe41-270890321

Ddl Cannabis: il Parlamento ha bocciato l’autoproduzione per soli 16 voti

191 voti a favore, 207 contro. Con questo scarto risicato è stato respinto dal Parlamento l’emendamento che avrebbe consentito l’autoproduzione di cannabis dietro ricetta medica. È successo ieri sera durante la votazione sulla proposta di legge per la cannabis terapeutica presentata da Anna Margherita Miotto (Pd).

in Cannabis / High times  19 ottobre 2017

Le opposizioni di Movimento 5 Stelle e Sinistra Italiana avevano presentato due emendamenti al testo di legge in discussione per consentire l’autoproduzione per i malati sia in forma personale che associativa, e avevano ottenuto che i due voti si tenessero a scrutinio segreto, sperando in questo modo che alcuni deputati del Pd disobbedissero alle direttive di partito, votando a favore grazie al segreto dell’urna.

La manovra non è riuscita per poco, influenzata anche dalle molte assenze tra i banchi. Gli emendamenti sono stati entrambi bocciati, rispettivamente con 189 sì e 210 no il primo e 191 sì e 207 no il secondo. Impossibile non sottolineare come, se tutti gli appartenenti dell’intergruppo parlamentare per la legalizzazione (forte di 220 membri) dopo aver per mesi sbandierato il loro favore alla riforma delle leggi proibizioniste, fossero stati almeno presenti ieri in aula gli emendamenti sarebbero passati.

Il Parlamento ha invece approvato la prima lettura della proposta di legge Miotto, una proposta nata nelle commissioni per volontà del governo, in contrapposizione alla proposta di legalizzazione, e che non comporterà nessun reale miglioramento, neppure per i malati che hanno diritto alle cure a base di cannabis. Una proposta “foglia di fico”, da approvare solo per poter dire ai media di aver fatto qualcosa in questo senso.

A votare con il governo, almeno nelle votazioni palesi, sono stati insieme Pd Forza e Italia, inclusi anche i parlamentari democratici che in passato avevano aderito all’intergruppo della legalizzazione. Tra questi anche Roberto Giachetti, ovvero colui che era stato primo firmatario del ddl per la legalizzazione, che ha spiegato di averlo fatto per “disciplina di partito”.

 

 

 

 

http://www.dolcevitaonline.it/ddl-cannabis-il-parlamento-ha-bocciato-lautoproduzione-per-soli-16-voti/